A detailed history of Bessemer Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 120 shares of AGIO stock, worth $4,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Holding current value
$4,242
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $4,942 - $5,966
120 New
120 $5,000
Q4 2019

Feb 04, 2020

SELL
$30.08 - $50.59 $691 - $1,163
-23 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$32.4 - $49.58 $745 - $1,140
23 New
23 $1,000
Q2 2018

Jul 25, 2018

SELL
$73.22 - $99.55 $7,834 - $10,651
-107 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$54.89 - $67.12 $5,873 - $7,181
107
107 $7,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.94B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.